share_log

邁博藥業-B:內幕消息公告國家藥品監督管理局批准核心產品CMAB009 恩立妥(西妥昔單抗 BETA 注射液)的上市註冊申請(NDA)

MABPHARM-B: INSIDE INFORMATION ANNOUNCEMENTAPPROVAL FROM THE NATIONAL MEDICAL PRODUCTSADMINISTRATION ON THE NEW DRUG APPLICATION (NDA)OF OUR CORE PRODUCT, CMAB009 (CETUXIMAB BETA INJECTION)

HKEX ·  Jun 25 04:58
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more